Mankind Pharma, the fourth-largest pharmaceutical company in the domestic market, is scouting for mergers and acquisitions, in-licensing deals to boost its domestic branded formulation business, the company's top executive said. The company is evaluating assets including brands to product portfolios, and even large assets.